Landon Z. Marshall, PharmD, PhD

Principal Health Outcomes Researcher
Prime Therapeutics
Eagan, MN

Landon Marshall, PharmD, PhD, is a Principal Health Outcomes researcher at Prime Therapeutics, where he analyzes the impact of high-cost drug therapies on clinical outcomes and total cost of care.
Prior to joining Prime, Dr. Marshall was a health economics and outcome research consultant conducting real-world assessments of cancer therapeutics seeking new and expanded indications under the FDA real world evidence program and he supported payer value communication initiatives by developing core value dossiers.
Dr. Marshall received his Doctor of Pharmacy degree from Presbyterian College School of Pharmacy and his Doctor of Philosophy degree from the University of Texas at Austin.

Presentation(s):

• (R6) GLP-1 Agonists for Weight Management within the Commercially Insured Market: How Real-world Evidence Can Inform Benefit Design

  Wednesday, October 16, 2024
  4:15 PM – 5:30 PM PT